Supplementary Figure S9 from Multiomic mapping of acquired chromosome 1 copy number and structural variants to identify therapeutic vulnerabilities in multiple myeloma.

Eileen M. Boyle; Patrick Blaney; James H. Stoeckle; Yubao Wang; Hussein Ghamlouch; Dylan Gagler; Marc Braunstein; Louis Williams; Avital Tenenbaum; Ariel Siegel; Xiaoyi Chen; Gaurav Varma; Jason Avigan; Alexander Li; Monica Jinsi; David Kaminetzky; Arnaldo Arbini; Lydia Montes; Jill Corre; Even H. Rustad; Ola Landgren; Francesco Maura; Brian A. Walker; Michael Bauer; Benedetto Bruno; Aristotelis Tsirigos; Faith E. Davies; Gareth J. Morgan

doi:10.1158/1078-0432.27033277.v1

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Impact of additional chromosome 1 structural events on outcome A.Effect of amp(1q) with or without a total (TT) gain on PFS B. Effect of amp(1q) on OS

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Boyle et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db64358752386e https://doi.org/10.1158/1078-0432.27033277.v1

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S9 from Multiomic mapping of acquired chromosome 1 copy number and structural variants to identify therapeutic vulnerabilities in multiple myeloma.

Ask about this paper

Abstract

Discussion

Cite This Study

Supplementary Figure S9 from Multiomic mapping of acquired chromosome 1 copy number and structural variants to identify therapeutic vulnerabilities in multiple myeloma.

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading